Jefferies initiated coverage on VectivBio with a new price target
$VECT
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Jefferies initiated coverage of VectivBio with a rating of Buy and set a new price target of $18.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/13/2022 | $18.00 | Buy | Jefferies |
| 7/1/2022 | $23.00 | Overweight | Piper Sandler |